Effective from
- Added
Long term (current) use of myelosuppressive agent
Billable diagnosis code
CDC/NCHS · FY2023any therapeutic drug level monitoring (Z51.81)
Coverage depends on the payer, service and applicable policy. A billable code does not guarantee payment.
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗Grouping depends on the complete encounter and CMS grouper logic.
2026-04-01 – 2026-09-30
CMS · MS-DRG 43.1First observed · 2022-10-01
Latest recorded change · FY2023
Effective from
Long term (current) use of myelosuppressive agent
Billable diagnosis code
CDC/NCHS · FY2023| All editions | Effective from | Code history |
|---|---|---|
| FY2023 | 2022-10-01 | Added |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Long term (current) use of hydroxyurea
long term (current) drug use for prophylactic purposes
any therapeutic drug level monitoring (Z51.81)
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Previous assignment: Z79.899
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| Z79.60 | Long term (current) use of unspecified immunomodulators and immunosuppressants | Billable / specific |
| Z79.61 | Long term (current) use of immunomodulator | Billable / specific |
| Z79.62 | Long term (current) use of immunosuppressant | Category · further specificity required |
| Z79.63 | Long term (current) use of chemotherapeutic agent | Category · further specificity required |
| Z79.69 | Long term (current) use of other immunomodulators and immunosuppressants | Billable / specific |
Official titles and instructions are preserved in their source language. Official sources ↗